Biessels, G., Janssen, J., van den Berg, E., Zinman, B., Espeland, M., Mattheus, M., … CAROLINA®, investigators. (2018). Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus. BMC Neurology, 18(1), 7. https://doi.org/10.1186/s12883-018-1014-7 (Original work published 2018)

Tran, S., Retnakaran, R., Zinman, B., & Kramer, C. (2018). Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials. Diabetes, Obesity & Metabolism, 20 Suppl 1, 68-76. https://doi.org/10.1111/dom.13137

Mann, J., Ørsted, D., Brown-Frandsen, K., Marso, S., Poulter, N., Rasmussen, S., … and, I. L. S. C. (2017). Liraglutide and Renal Outcomes in Type 2 Diabetes. The New England Journal of Medicine, 377(9), 839-848. https://doi.org/10.1056/NEJMoa1616011 (Original work published 2017)

Marso, S., McGuire, D., Zinman, B., Poulter, N., Emerson, S., Pieber, T., … Study, G. D. (2017). Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. The New England Journal of Medicine, 377(8), 723-732. https://doi.org/10.1056/NEJMoa1615692 (Original work published 2017)